The current institutional shareholding score of Protalix Biotherapeutics Inc is 3.00, ranking 94 out of 157 in the Pharmaceuticals industry. The latest institutional shareholding proportion is 24.71%, representing a quarter-over-quarter increase of 38.20%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 1.52% of shares outstanding, with 0.01% decrease in holdings.